These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 9657111)

  • 1. Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection.
    Tennant BC; Baldwin BH; Graham LA; Ascenzi MA; Hornbuckle WE; Rowland PH; Tochkov IA; Yeager AE; Erb HN; Colacino JM; Lopez C; Engelhardt JA; Bowsher RR; Richardson FC; Lewis W; Cote PJ; Korba BE; Gerin JL
    Hepatology; 1998 Jul; 28(1):179-91. PubMed ID: 9657111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of mitochondrial DNA, destruction of mitochondria, and accumulation of lipid droplets result from fialuridine treatment in woodchucks (Marmota monax).
    Lewis W; Griniuviene B; Tankersley KO; Levine ES; Montione R; Engelman L; de Courten-Myers G; Ascenzi MA; Hornbuckle WE; Gerin JL; Tennant BC
    Lab Invest; 1997 Jan; 76(1):77-87. PubMed ID: 9010451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.
    McKenzie R; Fried MW; Sallie R; Conjeevaram H; Di Bisceglie AM; Park Y; Savarese B; Kleiner D; Tsokos M; Luciano C
    N Engl J Med; 1995 Oct; 333(17):1099-105. PubMed ID: 7565947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-targeted antiviral nucleosides: enhanced antiviral activity of phosphatidyl-dideoxyguanosine versus dideoxyguanosine in woodchuck hepatitis virus infection in vivo.
    Korba BA; Xie H; Wright KN; Hornbuckle WE; Gerin JL; Tennant BC; Hostetler KY
    Hepatology; 1996 May; 23(5):958-63. PubMed ID: 8621175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks.
    Lu M; Hilken G; Yang D; Kemper T; Roggendorf M
    J Virol; 2001 Apr; 75(8):3811-8. PubMed ID: 11264370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity of ganciclovir, 9-(1,3-dihydroxy-2-propoxymethyl) guanine against woodchuck hepatitis virus: quantitative measurement of woodchuck hepatitis virus DNA using storage phosphor technology.
    Zahm FE; Bonino F; Giuseppetti R; Rapicetta M
    Ital J Gastroenterol Hepatol; 1998 Oct; 30(5):510-6. PubMed ID: 9836108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks.
    Korba BE; Cote P; Hornbuckle W; Schinazi R; Gangemi JD; Tennant BC; Gerin JL
    Antivir Ther; 2000 Jun; 5(2):95-104. PubMed ID: 10971862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
    Peek SF; Cote PJ; Jacob JR; Toshkov IA; Hornbuckle WE; Baldwin BH; Wells FV; Chu CK; Gerin JL; Tennant BC; Korba BE
    Hepatology; 2001 Jan; 33(1):254-66. PubMed ID: 11124844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic hepatocarcinogenic effect of hepadnaviral infection and dietary aflatoxin B1 in woodchucks.
    Bannasch P; Khoshkhou NI; Hacker HJ; Radaeva S; Mrozek M; Zillmann U; Kopp-Schneider A; Haberkorn U; Elgas M; Tolle T
    Cancer Res; 1995 Aug; 55(15):3318-30. PubMed ID: 7614467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral efficacy and pharmacokinetics of oral adefovir dipivoxil in chronically woodchuck hepatitis virus-infected woodchucks.
    Cullen JM; Li DH; Brown C; Eisenberg EJ; Cundy KC; Wolfe J; Toole J; Gibbs C
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2740-5. PubMed ID: 11557463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an immunogenic complex containing WHV viral particles and non-neutralizing anti-HBs antibodies on the outcome of WHV infection in woodchucks.
    D'Ugo E; Canitano A; Catone S; Giuseppetti R; Kondili LA; Argentini C; Rapicetta M
    J Med Virol; 2011 Jan; 83(1):178-86. PubMed ID: 21108357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infection.
    Jacquard AC; Nassal M; Pichoud C; Ren S; Schultz U; Guerret S; Chevallier M; Werle B; Peyrol S; Jamard C; Rimsky LT; Trepo C; Zoulim F
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2683-92. PubMed ID: 15215126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S; Cote PJ; Korba BE; Butler SD; George AL; Tochkov IA; Delaney WE; Xiong S; Gerin JL; Tennant BC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2720-8. PubMed ID: 15980342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infection.
    Menne S; Roneker CA; Tennant BC; Korba BE; Gerin JL; Cote PJ
    Intervirology; 2002; 45(4-6):237-50. PubMed ID: 12566706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial and cellular toxicity induced by fialuridine in human muscle in vitro.
    Semino-Mora C; Leon-Monzon M; Dalakas MC
    Lab Invest; 1997 Apr; 76(4):487-95. PubMed ID: 9111511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.
    Wang J; Gujar SA; Cova L; Michalak TI
    J Virol; 2007 Jan; 81(2):903-16. PubMed ID: 17079319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous response for a mammalian hepadnavirus infection to acyclovir: drug-arrested intermediates of minus-strand viral DNA synthesis are enveloped and secreted from infected cells as virion-like particles.
    Tencza MG; Newbold JE
    J Med Virol; 1997 Jan; 51(1):6-16. PubMed ID: 8986943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of isolated antibodies to woodchuck hepatitis virus core antigen is indicative of occult infection.
    Coffin CS; Pham TN; Mulrooney PM; Churchill ND; Michalak TI
    Hepatology; 2004 Nov; 40(5):1053-61. PubMed ID: 15382154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.